Expertise in
20
conditions

Shen Q. Qu

No.389 Xincun Road, 
Putuo, CN 
Expertise in
20
conditions
No.389 Xincun Road, 
Putuo, CN 

Overview

Shen Qu practices practicing medicine in Putuo, China.

Mr. Qu is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Type A Insulin Resistance Syndrome, Acanthosis Nigricans, Melasma, Sleeve Gastrectomy, and Gastrectomy.

He is actively involved in clinical research, co-authoring 432 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

No.389 Xincun Road, Putuo, 200065, China
Other Locations
No. 301 Middle Yanchang Road, Shanghai, 200072, China
389 Xin Cun Road, Putuo, 200065, China
389 Xin Cun Road, Xincun, 200065, China
301 Middle Yan Chang Road, Shanghai, 200072, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec
Study Phase: Phase 3
A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog, LY2963016, to Lantus® in Combination With Mealtime Insulin Lispro in Adult Chinese Patients With Type 1 Diabetes Mellitus
A Prospective, Randomized, Open-Label Comparison of a Long-Acting Basal Insulin Analog, LY2963016, to Lantus® in Combination With Mealtime Insulin Lispro in Adult Chinese Patients With Type 1 Diabetes Mellitus
Enrollment Status: Completed
Publish Date: March 29, 2021
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

427 Total Publications

Intrascleral fixation with double-flanged prolene: a stable technique for intraocular lens implantation.
Intrascleral fixation with double-flanged prolene: a stable technique for intraocular lens implantation.
Journal: Retina (Philadelphia, Pa.)
Published: July 21, 2026

Frequently Asked Questions about Shen Q. Qu

Is Shen Q. Qu a top-rated expert for Type A Insulin Resistance Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Shen Q. Qu is classified as an Elite expert for Type A Insulin Resistance Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Shen Q. Qu participate in research or clinical trials?

Yes. Shen Q. Qu has published 427 articles and abstracts on conditions like Type A Insulin Resistance Syndrome. You can view a list of Shen Q. Qu's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Qu's expertise for a condition
ConditionClose
View All 13 Advanced Conditions
View All 40 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile